CID is 2754
synonyms found at PubChem are:
cilostazol, 73963-72-1, Pletal, Cilostazole, Pletaal, Cilostazolum, OPC-13013, Cilostazolum [INN-Latin], OPC 13013, OPC 21, OPC-21, Cilostazol [INN:JAN], Pletal (TN), UNII-N7Z035406B, C20H27N5O2, 6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydro-2(1H)-quinolinone, BRN 3632107, 6-[4-(1-cyclohexyltetrazol-5-yl)butoxy]-3,4-dihydro-1H-quinolin-2-one, 3,4-Dihydro-6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-2(1H)-quinolinone, 6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydroquinolin-2(1H)-one, MLS000028470, CHEBI:31401, 6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydrocarbostyril, N7Z035406B, NCGC00015207-07, SMR000058428, 6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone, 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydroquinolin-2(1H)-one, C 0737, DSSTox_CID_25132, DSSTox_RID_80693, DSSTox_GSID_45132, Q-200854, 6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxyl)-3,4-dihydrocarobostyril, 2(1H)-Quinolinone, 3,4-dihydro-6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-, 2(1H)-Quionlinone, 6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydro-, 6-[4-(1-cyclohexyl-1H-1,2,3,4-tetrazol-5-yl)butoxy]-1,2,3,4-tetrahydroquinolin-2-one, 6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)-butoxy]-3,4-dihydro-2(1H)-quinolinone, CPD000058428, CAS-73963-72-1, SR-01000003107, Cilostazol,(S), Pletal, Cilostazol, CILASTAZOL, RETAL, Pleta (TN), Cilostazol [USAN:USP:INN:BAN:JAN], Tocris-1692, Opera_ID_488, Spectrum2_001118, Spectrum3_001170, Spectrum4_000772, Spectrum5_001762, Lopac-C-0737, Otsuka brand of cilostazol, CHEMBL799, D03VPC, D0E7MJ, AC1L1EE2, Lopac0_000218, REGID_for_CID_2754, SCHEMBL16128, BSPBio_002759, KBioGR_001184, MLS000758281, MLS000759507, MLS001076067, MLS002153891, SPECTRUM1505230, SPBio_001256, GTPL7148, Cilostazol (JP15/USAN/INN), Cilostazol (JP17/USAN/INN), DTXSID9045132, CTK8F0315, HSDB 8312, KBio3_002259, MolPort-001-758-007, RRGUKTPIGVIEKM-UHFFFAOYSA-N, ZX-AFC000447, BCPP000279, HMS1922N15, HMS2093M14, HMS2096F16, HMS2234C06, HMS3260L17, HMS3268O09, HMS3654J13, HMS3713F16, Pharmakon1600-01505230, ACT02663, BCP03724, ZINC1552174, ZX-AT018851, Tox21_110098, Tox21_500218, BI7396, BS0279, CCG-39646, KM1582, MFCD00866780, NSC758936, s1294, AKOS015855512, Cilostazol, >=98% (HPLC), powder, OPC 13013; OPC 21; Pletaal, Tox21_110098_1, AC-4334, AM90304, API0002016, BCP9000530, CL23867, CS-1759, DB01166, KS-5154, LP00218, MCULE-8893820969, NSC-758936, OR13681, RP18108, NCGC00015207-01, NCGC00015207-02, NCGC00015207-03, NCGC00015207-04, NCGC00015207-05, NCGC00015207-06, NCGC00015207-08, NCGC00015207-09, NCGC00015207-10, NCGC00015207-11, NCGC00015207-12, NCGC00022153-02, NCGC00022153-04, NCGC00022153-05, NCGC00022153-06, NCGC00022153-07, NCGC00260903-01, AJ-26894, AN-12078, CC-25783, CJ-24365, HY-17464, SAM001246734, SAM001247085, SC-14107, BCP0726000145, SBI-0050206.P002, AB0012441, AB2000035, LS-142693, TC-063580, TL8005113, EU-0100218, FT-0602474, FT-0645036, ST24046323, D01896, J90029, AB00382988-14, AB00382988_15, AB00382988_16, 963C721, A837982, C-21103, SR-01000003107-2, SR-01000003107-4, SR-01000003107-7, BRD-K67017579-001-04-2, BRD-K67017579-001-05-9, BRD-K67017579-001-07-5, BRD-K67017579-001-13-3, BRD-K67017579-001-17-4, SR-01000003107-10, Cilastatin sodium, Antibiotic for Culture Media Use Only, Cilostazol, United States Pharmacopeia (USP) Reference Standard, 6-[4-(1-cyclohexyl-1,2,3,4-tetrazol-5-yl)butoxy]-3,4-dihydrocarbostyril, 6-[4-(1-cyclohexyl-5-tetrazolyl)butoxy]-3,4-dihydro-1H-quinolin-2-one, 6-[4-(l-cyclohexyl-1,2,3,4-tetrazol-5-yl)butoxyl]-3,4-dihydrocarbostyril, Cilostazol, Pharmaceutical Secondary Standard; Certified Reference Material, 2(1H)-Quinolinone, 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-, 6-[4-(1-cyclohexyl-1,2,3,4-tetrazol-5-yl)butoxy]-3,4-dihydro-1H-quinolin-2-one, 6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)-butoxy]-3,4-dihydro-1H-quinolin-2-one, 6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-2-oxo-1,2,3,4-tetrahydroquinoline